期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Commercial Use and Development Trends of Mobile TV Terminal Chips
1
作者 Zhang ZhijiangLi XiangpingZhang Fan(China Unicom Co. Ltd., Beijing 100032, China) 《ZTE Communications》 2007年第1期51-53,共3页
Mobile TV is growing popular worldwide. It puts new hardware requirements on the handset, requiring a tuner, a demodulator and a decoder to receive and process signals that challenge the power consumption and size of ... Mobile TV is growing popular worldwide. It puts new hardware requirements on the handset, requiring a tuner, a demodulator and a decoder to receive and process signals that challenge the power consumption and size of handsets. These special terminal chips can solve these problems and stand as a prerequisite for broadcasting TV to mobile phones. The commercial mobile TV handsets have been brought to the market, which use the integrated single-chip, the dual/multi mode chip, or the TV receiver integrated in an SD card. These small chips with low power consumption will help popularize mobile TV services. 展开更多
关键词 TV Commercial use and Development Trends of Mobile TV Terminal Chips DVB ISDB
下载PDF
Electcoms Puts ZTE GoTa Network into Commercial Use
2
《ZTE Communications》 2007年第1期25-25,共1页
Electcoms, the largest professional trunking network operator in Malaysia, has launched a network based on ZTE’s Global Open Trunking Architecture (GoTa). The launch, in Kuala Lumpur, Malaysia,
关键词 GOTA ZTE Electcoms Puts ZTE GoTa Network into Commercial use
下载PDF
Genome editing in plants with MAD7 nuclease 被引量:5
3
作者 Qiupeng Lin Zixu Zhu +8 位作者 Guanwen Liu Chao Sun Dexing Lin Chenxiao Xue Shengnan Li Dandan Zhang Caixia Gao Yanpeng Wang Jin-Long Qiu 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2021年第6期444-451,共8页
MAD7 is an engineered nuclease of the Class 2 type V-A CRISPR-Cas(Cas12 a/Cpf1)family with a low level of homology to canonical Cas12 a nucleases.It has been publicly released as a royalty-free nuclease for both acade... MAD7 is an engineered nuclease of the Class 2 type V-A CRISPR-Cas(Cas12 a/Cpf1)family with a low level of homology to canonical Cas12 a nucleases.It has been publicly released as a royalty-free nuclease for both academic and commercial use.Here,we demonstrate that the CRISPR-MAD7 system can be used for genome editing and recognizes T-rich PAM sequences(YTTN)in plants.Its editing efficiency in rice and wheat is comparable to that of the widely used CRISPR-Lb Cas12 a system.We develop two variants,MAD7-RR and MAD7-RVR that increase the target range of MAD7,as well as an M-AFID(a MAD7-APOBEC fusion-induced deletion)system that creates predictable deletions from 50-deaminated Cs to the MAD7-cleavage site.Moreover,we show that MAD7 can be used for multiplex gene editing and that it is effective in generating indels when combined with other CRISPR RNA orthologs.Using the CRISPR-MAD7 system,we have obtained regenerated mutant rice and wheat plants with up to 65.6%efficiency. 展开更多
关键词 MAD7 nuclease CRISPR-Cas12a Plant genome editing Royalty-free Commercial use
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部